의약품 관련 법령
BfArM Form: Notification by the Pharmacovigilance Commissioner
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-11-19 | 조회수 | 920 |
국가정보 | 유럽>독일 | ||
출처 | BfArM | ||
원문 | www.bfarm.de | ||
첨부파일 |
This form is available in a ready-to-use format.
According to the section 3 of § 63a of the German Medicines Act (AMG), pharmaceutical companies are obliged to notify a qualified person for pharmacovigilance to the higher federal authority of the competent state authority and possibly also at the Paul-Ehrlich-Institut. The report may preferably be submitted electronically to pv-inspek...
According to the section 3 of § 63a of the German Medicines Act (AMG), pharmaceutical companies are obliged to notify a qualified person for pharmacovigilance to the higher federal authority of the competent state authority and possibly also at the Paul-Ehrlich-Institut. The report may preferably be submitted electronically to pv-inspek...
- 이전글 Disposition 1686/2018: Amends Disposition 8259/2017 wihch Determines the Reference Product for Performing Chemical and Physical Tests for Levothyroxine
- 다음글 Paul Ehrlich Institute Presentation: Organization Chart